Schonfeld Strategic Advisors LLC Travere Therapeutics, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 185,123 shares of TVTX stock, worth $3.32 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
185,123
Previous 440,957
58.02%
Holding current value
$3.32 Million
Previous $3.4 Million
55.25%
% of portfolio
0.01%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding TVTX
# of Institutions
184Shares Held
89.8MCall Options Held
137KPut Options Held
181K-
Black Rock Inc. New York, NY7.64MShares$137 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$135 Million0.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$132 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$119 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.48MShares$80.5 Million1.14% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.15B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...